Overview

Pharmacogenetic Study of Mirtazapine Response in Depressed Patients

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pharmacogenetic study predict Mirtazapine responsiveness in advance before the appearance of the drug effect until 4-6 weeks after administration of Mirtazapine.
Phase:
N/A
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Mianserin
Mirtazapine